{"SLR NAME":"The divergent protective effects of angiotensin-converting enzyme
inhibitors and angiotensin receptor blockers on clinical outcomes
of coronavirus disease 2019 (COVID-19): a systematic review and
meta-analysis","References":[{"title1":"Angiotensin?converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe <styled-content style="fixed-case" toggle="no">COVID?19</styled-content> infection in a multi?site <styled-content style="fixed-case" toggle="no">UK</styled-content> acute hospital trust","References":[{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"}]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy","References":[]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","References":[]},{"title2":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","References":[{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"}]},{"title2":"Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors","References":[]},{"title2":"COVID-19 and the cardiovascular system","References":[{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"}]},{"title2":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","References":[{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"}]},{"title2":"SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?","References":[{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"}]},{"title2":"COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease","References":[{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"}]},{"title2":"Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers","References":[{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"}]},{"title2":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","References":[{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"}]},{"title2":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","References":[{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"}]},{"title2":"CogStack - experiences of deploying integrated information retrieval and extraction services in a large National Health Service Foundation Trust hospital","References":[{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"}]},{"title2":"Semantic computational analysis of anticoagulation use in atrial fibrillation from real world data","References":[{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"}]},{"title2":"MedCAT - medical concept annotation tool","References":[]},{"title2":"MIMIC-III, a freely accessible critical care database","References":[{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"}]},{"title2":"Conducting sensitivity analysis for unmeasured confounding in observational studies using E-values: the evalue package","References":[]},{"title2":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China","References":[]},{"title2":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","References":[]},{"title2":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19","References":[{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"}]},{"title2":"Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study","References":[]},{"title2":"Should ethnicity serve as the basis for clinical trial design? Importance of race/ethnicity in clinical trials: lessons from the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","References":[]},{"title2":"Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19","References":[]},{"title2":"Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors","References":[{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"}]},{"title2":"Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers","References":[]}]},{"title1":"ReninAngiotensinAldosterone System Inhibitors and Risk of Covid-19","References":[{"title2":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.","References":[]},{"title2":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19.","References":[{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."}]},{"title2":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.","References":[]},{"title2":"Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling","References":[]},{"title2":"Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease.","References":[{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."},{"title3":"Elevated%20plasma%20angiotensin%20converting%20enzyme%202%20activity%20is%20an%20independent%20predictor%20of%20major%20adverse%20cardiac%20events%20in%20patients%20with%20obstructive%20coronary%20artery%20disease."}]},{"title2":"Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.","References":[]},{"title2":"Combined antihypertensive therapies that increase expression of cardioprotective biomarkers associated with the renin-angiotensin and kallikrein-kinin systems.","References":[]},{"title2":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","References":[{"title3":"Are%20patients%20with%20hypertension%20and%20diabetes%20mellitus%20at%20increased%20risk%20for%20COVID-19%20infection?"},{"title3":"Are%20patients%20with%20hypertension%20and%20diabetes%20mellitus%20at%20increased%20risk%20for%20COVID-19%20infection?"},{"title3":"Are%20patients%20with%20hypertension%20and%20diabetes%20mellitus%20at%20increased%20risk%20for%20COVID-19%20infection?"},{"title3":"Are%20patients%20with%20hypertension%20and%20diabetes%20mellitus%20at%20increased%20risk%20for%20COVID-19%20infection?"},{"title3":"Are%20patients%20with%20hypertension%20and%20diabetes%20mellitus%20at%20increased%20risk%20for%20COVID-19%20infection?"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China.","References":[{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."}]},{"title2":"Losartan, an antagonist of AT1 receptor for angiotensin II, attenuates lipopolysaccharide-induced acute lung injury in rat.","References":[]},{"title2":"Losartan, a selective antagonist of AT1 receptor, attenuates acute lung injury induced by seawater inhalation in rats.","References":[]},{"title2":"Losartan attenuates ventilator-induced lung injury.","References":[]},{"title2":"Angiotensin-converting enzyme inhibitor captopril prevents oleic acid-induced severe acute lung injury in rats.","References":[]},{"title2":"Landiolol hydrochloride ameliorates acute lung injury in a rat model of early sepsis through the suppression of elevated levels of pulmonary endothelin-1.","References":[]},{"title2":"Esmolol attenuates lung injury and inflammation in severe acute pancreatitis rats.","References":[]},{"title2":"Heart disease and stroke statistics : 2019 update: a report from the American Heart Association.","References":[]},{"title2":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.","References":[]},{"title2":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension.","References":[{"title3":"Renin-angiotensin%20system%20inhibitors%20improve%20the%20clinical%20outcomes%20of%20COVID-19%20patients%20with%20hypertension."},{"title3":"Renin-angiotensin%20system%20inhibitors%20improve%20the%20clinical%20outcomes%20of%20COVID-19%20patients%20with%20hypertension."},{"title3":"Renin-angiotensin%20system%20inhibitors%20improve%20the%20clinical%20outcomes%20of%20COVID-19%20patients%20with%20hypertension."},{"title3":"Renin-angiotensin%20system%20inhibitors%20improve%20the%20clinical%20outcomes%20of%20COVID-19%20patients%20with%20hypertension."},{"title3":"Renin-angiotensin%20system%20inhibitors%20improve%20the%20clinical%20outcomes%20of%20COVID-19%20patients%20with%20hypertension."},{"title3":"Renin-angiotensin%20system%20inhibitors%20improve%20the%20clinical%20outcomes%20of%20COVID-19%20patients%20with%20hypertension."},{"title3":"Renin-angiotensin%20system%20inhibitors%20improve%20the%20clinical%20outcomes%20of%20COVID-19%20patients%20with%20hypertension."},{"title3":"Renin-angiotensin%20system%20inhibitors%20improve%20the%20clinical%20outcomes%20of%20COVID-19%20patients%20with%20hypertension."},{"title3":"Renin-angiotensin%20system%20inhibitors%20improve%20the%20clinical%20outcomes%20of%20COVID-19%20patients%20with%20hypertension."},{"title3":"Renin-angiotensin%20system%20inhibitors%20improve%20the%20clinical%20outcomes%20of%20COVID-19%20patients%20with%20hypertension."}]}]},{"title1":"ReninAngiotensinAldosterone System Blockers and the Risk of Covid-19","References":[{"title2":"Physiology of local renin-angiotensin systems.","References":[]},{"title2":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.","References":[]},{"title2":"A pneumonia outbreak associated with a new coronavirus of probable bat origin.","References":[]},{"title2":"Pharmacologic modulation of ACE2 expression.","References":[{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."},{"title3":"Pharmacologic%20modulation%20of%20ACE2%20expression."}]},{"title2":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.","References":[]},{"title2":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","References":[{"title3":"Are%20patients%20with%20hypertension%20and%20diabetes%20mellitus%20at%20increased%20risk%20for%20COVID-19%20infection?"},{"title3":"Are%20patients%20with%20hypertension%20and%20diabetes%20mellitus%20at%20increased%20risk%20for%20COVID-19%20infection?"},{"title3":"Are%20patients%20with%20hypertension%20and%20diabetes%20mellitus%20at%20increased%20risk%20for%20COVID-19%20infection?"},{"title3":"Are%20patients%20with%20hypertension%20and%20diabetes%20mellitus%20at%20increased%20risk%20for%20COVID-19%20infection?"},{"title3":"Are%20patients%20with%20hypertension%20and%20diabetes%20mellitus%20at%20increased%20risk%20for%20COVID-19%20infection?"}]},{"title2":"Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?","References":[{"title3":"Can%20angiotensin%20receptor-blocking%20drugs%20perhaps%20be%20harmful%20in%20the%20COVID-19%20pandemic?"},{"title3":"Can%20angiotensin%20receptor-blocking%20drugs%20perhaps%20be%20harmful%20in%20the%20COVID-19%20pandemic?"},{"title3":"Can%20angiotensin%20receptor-blocking%20drugs%20perhaps%20be%20harmful%20in%20the%20COVID-19%20pandemic?"},{"title3":"Can%20angiotensin%20receptor-blocking%20drugs%20perhaps%20be%20harmful%20in%20the%20COVID-19%20pandemic?"},{"title3":"Can%20angiotensin%20receptor-blocking%20drugs%20perhaps%20be%20harmful%20in%20the%20COVID-19%20pandemic?"},{"title3":"Can%20angiotensin%20receptor-blocking%20drugs%20perhaps%20be%20harmful%20in%20the%20COVID-19%20pandemic?"},{"title3":"Can%20angiotensin%20receptor-blocking%20drugs%20perhaps%20be%20harmful%20in%20the%20COVID-19%20pandemic?"}]},{"title2":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19.","References":[{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19."}]},{"title2":"Renin-angiotensin system blockers and the COVID-19 pandemic.","References":[{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic."}]},{"title2":"Angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers and pneumonia risk among stroke patients.","References":[]},{"title2":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China.","References":[]},{"title2":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19).","References":[{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.","References":[{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.","References":[{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study."}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China.","References":[{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."}]},{"title2":"SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?","References":[{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"}]},{"title2":"HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19","References":[{"title3":"HFSA/ACC/AHA%20statement%20addresses%20concerns%20re:%20using%20RAAS%20antagonists%20in%20COVID-19"},{"title3":"HFSA/ACC/AHA%20statement%20addresses%20concerns%20re:%20using%20RAAS%20antagonists%20in%20COVID-19"},{"title3":"HFSA/ACC/AHA%20statement%20addresses%20concerns%20re:%20using%20RAAS%20antagonists%20in%20COVID-19"},{"title3":"HFSA/ACC/AHA%20statement%20addresses%20concerns%20re:%20using%20RAAS%20antagonists%20in%20COVID-19"},{"title3":"HFSA/ACC/AHA%20statement%20addresses%20concerns%20re:%20using%20RAAS%20antagonists%20in%20COVID-19"},{"title3":"HFSA/ACC/AHA%20statement%20addresses%20concerns%20re:%20using%20RAAS%20antagonists%20in%20COVID-19"},{"title3":"HFSA/ACC/AHA%20statement%20addresses%20concerns%20re:%20using%20RAAS%20antagonists%20in%20COVID-19"},{"title3":"HFSA/ACC/AHA%20statement%20addresses%20concerns%20re:%20using%20RAAS%20antagonists%20in%20COVID-19"}]},{"title2":"COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?","References":[{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"}]},{"title2":"Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19.","References":[]},{"title2":"Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes.","References":[]},{"title2":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial.","References":[{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."},{"title3":"Withdrawal%20of%20pharmacological%20treatment%20for%20heart%20failure%20in%20patients%20with%20recovered%20dilated%20cardiomyopathy%20(TRED-HF):%20an%20open-label,%20pilot,%20randomised%20trial."}]},{"title2":"Incidence, predictors, and outcomes associated with hypotensive episodes among heart failure patients receiving sacubitril/valsartan or enalapril: the PARADIGM-HF Trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure).","References":[]},{"title2":"Coronavirus emergency.","References":[]},{"title2":"Early cardiovascular protection by initial two-drug fixed-dose combination treatment vs. monotherapy in hypertension.","References":[]},{"title2":"Generating evidence from computerized healthcare utilization databases.","References":[]},{"title2":"Adherence with antihypertensive drug therapy and the risk of heart failure in clinical practice.","References":[]},{"title2":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.","References":[{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR."},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR."},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR."},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR."},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR."},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR."},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR."},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR."},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR."},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR."},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR."},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR."},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR."},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR."},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR."},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR."},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR."},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR."},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR."},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR."},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR."},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR."}]},{"title2":"A new population-based risk stratification tool was developed and validated for predicting mortality, hospital admissions, and health care costs.","References":[]},{"title2":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy.","References":[]}]},{"title1":"Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19","References":[{"title2":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.","References":[]},{"title2":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China.","References":[]},{"title2":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19).","References":[{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."},{"title3":"Cardiovascular%20implications%20of%20fatal%20outcomes%20of%20patients%20with%20coronavirus%20disease%202019%20(COVID-19)."}]},{"title2":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State.","References":[]},{"title2":"Seasonal influenza infections and cardiovascular disease mortality.","References":[{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."},{"title3":"Seasonal%20influenza%20infections%20and%20cardiovascular%20disease%20mortality."}]},{"title2":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","References":[{"title3":"Are%20patients%20with%20hypertension%20and%20diabetes%20mellitus%20at%20increased%20risk%20for%20COVID-19%20infection?"},{"title3":"Are%20patients%20with%20hypertension%20and%20diabetes%20mellitus%20at%20increased%20risk%20for%20COVID-19%20infection?"},{"title3":"Are%20patients%20with%20hypertension%20and%20diabetes%20mellitus%20at%20increased%20risk%20for%20COVID-19%20infection?"},{"title3":"Are%20patients%20with%20hypertension%20and%20diabetes%20mellitus%20at%20increased%20risk%20for%20COVID-19%20infection?"},{"title3":"Are%20patients%20with%20hypertension%20and%20diabetes%20mellitus%20at%20increased%20risk%20for%20COVID-19%20infection?"}]},{"title2":"Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts","References":[{"title3":"Cell%20type-specific%20expression%20of%20the%20putative%20SARS-CoV-2%20receptor%20ACE2%20in%20human%20hearts"},{"title3":"Cell%20type-specific%20expression%20of%20the%20putative%20SARS-CoV-2%20receptor%20ACE2%20in%20human%20hearts"},{"title3":"Cell%20type-specific%20expression%20of%20the%20putative%20SARS-CoV-2%20receptor%20ACE2%20in%20human%20hearts"},{"title3":"Cell%20type-specific%20expression%20of%20the%20putative%20SARS-CoV-2%20receptor%20ACE2%20in%20human%20hearts"},{"title3":"Cell%20type-specific%20expression%20of%20the%20putative%20SARS-CoV-2%20receptor%20ACE2%20in%20human%20hearts"},{"title3":"Cell%20type-specific%20expression%20of%20the%20putative%20SARS-CoV-2%20receptor%20ACE2%20in%20human%20hearts"},{"title3":"Cell%20type-specific%20expression%20of%20the%20putative%20SARS-CoV-2%20receptor%20ACE2%20in%20human%20hearts"},{"title3":"Cell%20type-specific%20expression%20of%20the%20putative%20SARS-CoV-2%20receptor%20ACE2%20in%20human%20hearts"},{"title3":"Cell%20type-specific%20expression%20of%20the%20putative%20SARS-CoV-2%20receptor%20ACE2%20in%20human%20hearts"}]},{"title2":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","References":[{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"}]},{"title2":"Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.","References":[]},{"title2":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","References":[]},{"title2":"The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.","References":[{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."},{"title3":"The%20vasoprotective%20axes%20of%20the%20renin-angiotensin%20system:%20physiological%20relevance%20and%20therapeutic%20implications%20in%20cardiovascular,%20hypertensive%20and%20kidney%20diseases."}]},{"title2":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.","References":[]},{"title2":"COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?","References":[{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"}]},{"title2":"HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19","References":[{"title3":"HFSA/ACC/AHA%20statement%20addresses%20concerns%20re:%20using%20RAAS%20antagonists%20in%20COVID-19"},{"title3":"HFSA/ACC/AHA%20statement%20addresses%20concerns%20re:%20using%20RAAS%20antagonists%20in%20COVID-19"},{"title3":"HFSA/ACC/AHA%20statement%20addresses%20concerns%20re:%20using%20RAAS%20antagonists%20in%20COVID-19"},{"title3":"HFSA/ACC/AHA%20statement%20addresses%20concerns%20re:%20using%20RAAS%20antagonists%20in%20COVID-19"},{"title3":"HFSA/ACC/AHA%20statement%20addresses%20concerns%20re:%20using%20RAAS%20antagonists%20in%20COVID-19"},{"title3":"HFSA/ACC/AHA%20statement%20addresses%20concerns%20re:%20using%20RAAS%20antagonists%20in%20COVID-19"},{"title3":"HFSA/ACC/AHA%20statement%20addresses%20concerns%20re:%20using%20RAAS%20antagonists%20in%20COVID-19"},{"title3":"HFSA/ACC/AHA%20statement%20addresses%20concerns%20re:%20using%20RAAS%20antagonists%20in%20COVID-19"}]},{"title2":"Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers","References":[]},{"title2":"Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance","References":[]},{"title2":"Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?","References":[]},{"title2":"Sex differences in immune responses.","References":[{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."},{"title3":"Sex%20differences%20in%20immune%20responses."}]},{"title2":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection.","References":[{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."},{"title3":"Sex-based%20differences%20in%20susceptibility%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%20infection."}]},{"title2":"COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal.","References":[{"title3":"COVID-19%20illness%20in%20native%20and%20immunosuppressed%20states:%20a%20clinical-therapeutic%20staging%20proposal."},{"title3":"COVID-19%20illness%20in%20native%20and%20immunosuppressed%20states:%20a%20clinical-therapeutic%20staging%20proposal."},{"title3":"COVID-19%20illness%20in%20native%20and%20immunosuppressed%20states:%20a%20clinical-therapeutic%20staging%20proposal."},{"title3":"COVID-19%20illness%20in%20native%20and%20immunosuppressed%20states:%20a%20clinical-therapeutic%20staging%20proposal."},{"title3":"COVID-19%20illness%20in%20native%20and%20immunosuppressed%20states:%20a%20clinical-therapeutic%20staging%20proposal."},{"title3":"COVID-19%20illness%20in%20native%20and%20immunosuppressed%20states:%20a%20clinical-therapeutic%20staging%20proposal."},{"title3":"COVID-19%20illness%20in%20native%20and%20immunosuppressed%20states:%20a%20clinical-therapeutic%20staging%20proposal."},{"title3":"COVID-19%20illness%20in%20native%20and%20immunosuppressed%20states:%20a%20clinical-therapeutic%20staging%20proposal."},{"title3":"COVID-19%20illness%20in%20native%20and%20immunosuppressed%20states:%20a%20clinical-therapeutic%20staging%20proposal."},{"title3":"COVID-19%20illness%20in%20native%20and%20immunosuppressed%20states:%20a%20clinical-therapeutic%20staging%20proposal."},{"title3":"COVID-19%20illness%20in%20native%20and%20immunosuppressed%20states:%20a%20clinical-therapeutic%20staging%20proposal."}]},{"title2":"Angiotensin converting enzyme 2: a double-edged sword.","References":[{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword."}]},{"title2":"COVID-19 illness and heart failure: a missing link?","References":[{"title3":"COVID-19%20illness%20and%20heart%20failure:%20a%20missing%20link?"},{"title3":"COVID-19%20illness%20and%20heart%20failure:%20a%20missing%20link?"},{"title3":"COVID-19%20illness%20and%20heart%20failure:%20a%20missing%20link?"},{"title3":"COVID-19%20illness%20and%20heart%20failure:%20a%20missing%20link?"},{"title3":"COVID-19%20illness%20and%20heart%20failure:%20a%20missing%20link?"},{"title3":"COVID-19%20illness%20and%20heart%20failure:%20a%20missing%20link?"},{"title3":"COVID-19%20illness%20and%20heart%20failure:%20a%20missing%20link?"},{"title3":"COVID-19%20illness%20and%20heart%20failure:%20a%20missing%20link?"},{"title3":"COVID-19%20illness%20and%20heart%20failure:%20a%20missing%20link?"},{"title3":"COVID-19%20illness%20and%20heart%20failure:%20a%20missing%20link?"},{"title3":"COVID-19%20illness%20and%20heart%20failure:%20a%20missing%20link?"},{"title3":"COVID-19%20illness%20and%20heart%20failure:%20a%20missing%20link?"},{"title3":"COVID-19%20illness%20and%20heart%20failure:%20a%20missing%20link?"},{"title3":"COVID-19%20illness%20and%20heart%20failure:%20a%20missing%20link?"}]}]},{"title1":"Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19","References":[{"title2":"The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.","References":[{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."},{"title3":"The%20species%20Severe%20acute%20respiratory%20syndrome-related%20coronavirus:%20classifying%202019-nCoV%20and%20naming%20it%20SARS-CoV-2."}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China.","References":[{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China."}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China.","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.","References":[{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study."}]},{"title2":"Blood pressure and the new ACC/AHA hypertension guidelines.","References":[]},{"title2":"US hypertension management guidelines: a review of the recent past and recommendations for the future.","References":[{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."},{"title3":"US%20hypertension%20management%20guidelines:%20a%20review%20of%20the%20recent%20past%20and%20recommendations%20for%20the%20future."}]},{"title2":"Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade.","References":[]},{"title2":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.","References":[]},{"title2":"A new coronavirus associated with human respiratory disease in China.","References":[]},{"title2":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.","References":[{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury."}]},{"title2":"New Coronavirus Pneumonia Prevention and Control Program.","References":[]},{"title2":"Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases Interim guidance.","References":[]},{"title2":"Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected.","References":[]},{"title2":"Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury.","References":[]},{"title2":"Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT/ACOTS).","References":[]},{"title2":"Comparison of imputation methods for missing laboratory data in medicine.","References":[{"title3":"Comparison%20of%20imputation%20methods%20for%20missing%20laboratory%20data%20in%20medicine."},{"title3":"Comparison%20of%20imputation%20methods%20for%20missing%20laboratory%20data%20in%20medicine."},{"title3":"Comparison%20of%20imputation%20methods%20for%20missing%20laboratory%20data%20in%20medicine."},{"title3":"Comparison%20of%20imputation%20methods%20for%20missing%20laboratory%20data%20in%20medicine."},{"title3":"Comparison%20of%20imputation%20methods%20for%20missing%20laboratory%20data%20in%20medicine."},{"title3":"Comparison%20of%20imputation%20methods%20for%20missing%20laboratory%20data%20in%20medicine."},{"title3":"Comparison%20of%20imputation%20methods%20for%20missing%20laboratory%20data%20in%20medicine."}]},{"title2":"Sensitivity analysis in observational research: introducing the E-Value.","References":[]},{"title2":"Web site and R Package for computing E-values.","References":[{"title3":"Web%20site%20and%20R%20Package%20for%20computing%20E-values."},{"title3":"Web%20site%20and%20R%20Package%20for%20computing%20E-values."},{"title3":"Web%20site%20and%20R%20Package%20for%20computing%20E-values."}]},{"title2":"Using the E-Value to assess the potential effect of unmeasured confounding in observational studies.","References":[]},{"title2":"Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician.","References":[]},{"title2":"A statement from the International Society of Hypertension on COVID-19.","References":[]},{"title2":"Clinical outcomes of current medical approaches for Middle East respiratory syndrome: a systematic review and meta-analysis.","References":[{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20outcomes%20of%20current%20medical%20approaches%20for%20Middle%20East%20respiratory%20syndrome:%20a%20systematic%20review%20and%20meta-analysis."}]},{"title2":"Clinical determinants of the severity of Middle East respiratory syndrome (MERS): a systematic review and meta-analysis.","References":[{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."},{"title3":"Clinical%20determinants%20of%20the%20severity%20of%20Middle%20East%20respiratory%20syndrome%20(MERS):%20a%20systematic%20review%20and%20meta-analysis."}]},{"title2":"Activation of 12-lipoxygenase in proinflammatory cytokine-mediated beta cell toxicity.","References":[]},{"title2":"Role of the immune system in hypertension.","References":[{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."},{"title3":"Role%20of%20the%20immune%20system%20in%20hypertension."}]},{"title2":"NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets.","References":[{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."},{"title3":"NADPH%20oxidases%20and%20oxidase%20crosstalk%20in%20cardiovascular%20diseases:%20novel%20therapeutic%20targets."}]},{"title2":"Endothelins in cardiovascular biology and therapeutics.","References":[]},{"title2":"Angiotensin-converting enzyme 2 in lung diseases.","References":[{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."},{"title3":"Angiotensin-converting%20enzyme%202%20in%20lung%20diseases."}]},{"title2":"Angiotensin-converting enzyme 2 protects from severe acute lung failure.","References":[{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure."}]},{"title2":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia.","References":[]},{"title2":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.","References":[{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury."}]},{"title2":"Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD.","References":[{"title3":"Comparative%20effects%20of%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20receptor%20blockers%20on%20the%20risk%20of%20pneumonia%20and%20severe%20exacerbations%20in%20patients%20with%20COPD."},{"title3":"Comparative%20effects%20of%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20receptor%20blockers%20on%20the%20risk%20of%20pneumonia%20and%20severe%20exacerbations%20in%20patients%20with%20COPD."},{"title3":"Comparative%20effects%20of%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20receptor%20blockers%20on%20the%20risk%20of%20pneumonia%20and%20severe%20exacerbations%20in%20patients%20with%20COPD."},{"title3":"Comparative%20effects%20of%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20receptor%20blockers%20on%20the%20risk%20of%20pneumonia%20and%20severe%20exacerbations%20in%20patients%20with%20COPD."},{"title3":"Comparative%20effects%20of%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20receptor%20blockers%20on%20the%20risk%20of%20pneumonia%20and%20severe%20exacerbations%20in%20patients%20with%20COPD."},{"title3":"Comparative%20effects%20of%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20receptor%20blockers%20on%20the%20risk%20of%20pneumonia%20and%20severe%20exacerbations%20in%20patients%20with%20COPD."},{"title3":"Comparative%20effects%20of%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20receptor%20blockers%20on%20the%20risk%20of%20pneumonia%20and%20severe%20exacerbations%20in%20patients%20with%20COPD."},{"title3":"Comparative%20effects%20of%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20receptor%20blockers%20on%20the%20risk%20of%20pneumonia%20and%20severe%20exacerbations%20in%20patients%20with%20COPD."},{"title3":"Comparative%20effects%20of%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20receptor%20blockers%20on%20the%20risk%20of%20pneumonia%20and%20severe%20exacerbations%20in%20patients%20with%20COPD."},{"title3":"Comparative%20effects%20of%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20receptor%20blockers%20on%20the%20risk%20of%20pneumonia%20and%20severe%20exacerbations%20in%20patients%20with%20COPD."},{"title3":"Comparative%20effects%20of%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20receptor%20blockers%20on%20the%20risk%20of%20pneumonia%20and%20severe%20exacerbations%20in%20patients%20with%20COPD."},{"title3":"Comparative%20effects%20of%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20receptor%20blockers%20on%20the%20risk%20of%20pneumonia%20and%20severe%20exacerbations%20in%20patients%20with%20COPD."},{"title3":"Comparative%20effects%20of%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20receptor%20blockers%20on%20the%20risk%20of%20pneumonia%20and%20severe%20exacerbations%20in%20patients%20with%20COPD."},{"title3":"Comparative%20effects%20of%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20receptor%20blockers%20on%20the%20risk%20of%20pneumonia%20and%20severe%20exacerbations%20in%20patients%20with%20COPD."},{"title3":"Comparative%20effects%20of%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20receptor%20blockers%20on%20the%20risk%20of%20pneumonia%20and%20severe%20exacerbations%20in%20patients%20with%20COPD."},{"title3":"Comparative%20effects%20of%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20receptor%20blockers%20on%20the%20risk%20of%20pneumonia%20and%20severe%20exacerbations%20in%20patients%20with%20COPD."},{"title3":"Comparative%20effects%20of%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20receptor%20blockers%20on%20the%20risk%20of%20pneumonia%20and%20severe%20exacerbations%20in%20patients%20with%20COPD."},{"title3":"Comparative%20effects%20of%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20receptor%20blockers%20on%20the%20risk%20of%20pneumonia%20and%20severe%20exacerbations%20in%20patients%20with%20COPD."},{"title3":"Comparative%20effects%20of%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20receptor%20blockers%20on%20the%20risk%20of%20pneumonia%20and%20severe%20exacerbations%20in%20patients%20with%20COPD."},{"title3":"Comparative%20effects%20of%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20receptor%20blockers%20on%20the%20risk%20of%20pneumonia%20and%20severe%20exacerbations%20in%20patients%20with%20COPD."}]},{"title2":"Hypertension: renin-angiotensin-aldosterone system alterations.","References":[]},{"title2":"Effect of a strategy of comprehensive vasodilation vs usual care on mortality and heart failure rehospitalization among patients with acute heart failure: the GALACTIC Randomized Clinical Trial.","References":[]},{"title2":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.","References":[]},{"title2":"Antimicrobial resistance in nephrology.","References":[{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."},{"title3":"Antimicrobial%20resistance%20in%20nephrology."}]}]}]}